enGene Holdings Inc. (NASDAQ: ENGN) Stock Information | RedChip

enGene Holdings Inc. (NASDAQ: ENGN) Listen to this Section


$5.75
-0.1500 ( -2.54% ) 10.9K

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Market Data


Open


$5.75

Previous close


$5.90

Volume


10.9K

Market cap


$268.97M

Day range


$5.48 - $6.13

52 week range


$5.10 - $43.00

Insider Ownership Transactions

Total Amount Purchased: -1,633,481.00 | $ -9,392,515.75

Date Type Amount Purchased Purchaser
2023-11-02 Sale -24555.00 Glickman Richard M
2023-11-02 Sale -1341790.00 BRUNK GERALD A
2023-11-02 Sale -130085.00 Forbion Growth Sponsor FEAC I B.V.
2023-11-02 Sale -137051.00 Hanson Jason David

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Mar 25, 2024
4 Insider transactions 1 Mar 20, 2024
4 Insider transactions 1 Mar 19, 2024
8-k 8K-related 14 Mar 11, 2024
10-q Quarterly Reports 83 Mar 11, 2024
4 Insider transactions 1 Feb 21, 2024
4 Insider transactions 1 Feb 21, 2024
8-k 8K-related 63 Feb 14, 2024
3 Insider transactions 2 Feb 02, 2024
10-k Annual reports 123 Jan 29, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.